GlassScriptPhysician profile
Manuel Lopez Diez
NPI 1144458100
$9,854.56
in general payments reported to CMS, 2019-2025
35 companies · $965 in 2025
The $965 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,835 · 2020: $739 · 2021: $1,506 · 2022: $1,656 · 2023: $1,035 · 2024: $1,117 · 2025: $965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,891 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,891.31 |
| Travel and Lodging | $225.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,106.16 | 2019-2023 | Proclaim |
| Medtronic, INC. | $1,302.55 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Vertos Medical, INC. | $1,170.33 | 2021-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $442.82 | 2021-2024 | Sprint Pns System |
| Painteq LLC | $385.80 | 2021-2024 | Painteq |
| Boston Scientific Corporation | $324.34 | 2019-2024 | |
| Globus Medical, INC. | $289.24 | 2025 | Senza, Vyrsa V1 |
| Protega Pharmaceutials INC | $212.99 | 2022-2025 | Roxybond |
| Si-Bone, INC. | $209.88 | 2019-2025 | |
| Abbvie INC. | $149.15 | 2021-2025 | |
| Flowonix Medical Incorporated | $140.38 | 2019 | |
| Stryker Corporation | $125.04 | 2025 | Mild Device Kit |
| Nevro Corp. | $116.38 | 2023-2024 | Senza |
| Stimwave Technologies Incorporated | $103.44 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $94.08 | 2023-2025 | Xtampza, Belbuca |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $78.90 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.76 | 2019-2020 | |
| Amgen INC. | $67.55 | 2019-2022 | |
| Virtus Pharmaceuticals LLC | $52.99 | 2021 | |
| Daiichi Sankyo INC. | $42.50 | 2019 | |
| Saluda Medical Americas, INC. | $39.94 | 2022-2025 | Evoke |
| Averitas Pharma INC. | $39.24 | 2024 | Qutenza |
| Pfizer INC. | $35.43 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $32.99 | 2022-2023 | Seglentis |
| Orthogenrx INC. | $32.71 | 2019 | |
| Relievant Medsystems, INC. | $25.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $25.50 | 2019 | |
| Biotronik Nro, INC. | $23.49 | 2025 | Prospera |
| Zyla Life Sciences, INC. | $23.26 | 2019 | |
| Depuy Synthes Sales INC. | $20.77 | 2019 | |
| Curonix LLC | $19.41 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Therapeutics, INC. | $16.05 | 2019 | |
| Medtronic USA, INC. | $13.66 | 2020 | |
| Nalu Medical, INC. | $11.72 | 2021 | |
| Lilly USA, LLC | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Lopez Diez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.